NCT06849804

Brief Summary

The aim of this study is to evaluate the efficacy of ultrasound guided Erector block versus caudal block versus local wound infiltration perioperatively according to: Primary outcome: to assess and compare the postoperative analgesic effect using pain score: Faces Legs Activity Cry Consolability tool (FLACC, 0- 10) at 15 min, 30 min and 1, 2, 3 and 4 h after operation Secondary outcomes: First dose of fentanyl as a rescue analgesia in dose of 0.5 μg/kg. Total doses of fentanyl as a rescue analgesia. Demographic data: age, sex, weight, ASA class. Hemodynamic parameter (MAP in (mm/hg) and heart rate (beats/minute)) Motor function will be assessed using the following scale: 0, no motor block; 1, able to move legs; 2, unable to move legs. Assessment of sedation will be done with objective score based on eye opening: 0- spontaneously, 1- on verbal stimulation, 2- on physical stimulation Adverse events: bradycardia, hypotension, respiratory depression, local anesthesia toxicity, subarachnoid injection in caudal block, PONV, agitation, or urinary catheterization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2025

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

February 9, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 27, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2025

Completed
Last Updated

January 16, 2026

Status Verified

January 1, 2026

Enrollment Period

5 months

First QC Date

February 9, 2025

Last Update Submit

January 15, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Faces Legs Activity Cry Consolability tool (FLACC, 0- 10) at 15 min, 30 min and 1, 2, 3 and 4 h after operation

    4 hours

Secondary Outcomes (1)

  • Analgesic effect of the block

    4 hours

Study Arms (3)

Group E

ACTIVE COMPARATOR

Ultrasound guided erector spinae block

Procedure: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)

Group C

ACTIVE COMPARATOR

Ultrasound guided caudal block

Procedure: Caudal Block Anesthesia

Group L

ACTIVE COMPARATOR

Local infiltration of the wound

Procedure: Local infiltration in the wound

Interventions

Local Infiltration Group will receive 0.2 ml/kg 0.25% bupivacaine

Group L

Group E (n=25): Erector spinae plain block group will receive 0.5 ml/kg of 0.25%bupivacaine.

Group E

Caudal block group will receive 1 ml/kg of 0.25% bupivacaine

Group C

Eligibility Criteria

Age24 Months - 84 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may not qualify if:

  • Parents refusal. Coagulopathy. Allergy to local anesthesia. Local infection at the site of injection. Neurological anomalies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mohamed Zakarea Wfa

Tanta, Tanta, +20, Egypt

Location

MeSH Terms

Conditions

Agnosia

Interventions

ParapsychologyDental OcclusionBupivacaine

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Behavioral SciencesBehavioral Disciplines and ActivitiesDentistryDental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Group E : erector spinae block ultrasound guided Group C: ultrasound guided caudal block Group L: local infiltration
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assisted professor

Study Record Dates

First Submitted

February 9, 2025

First Posted

February 27, 2025

Study Start

January 20, 2025

Primary Completion

June 10, 2025

Study Completion

August 15, 2025

Last Updated

January 16, 2026

Record last verified: 2026-01

Locations